SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001578563-24-000320
Filing Date
2024-06-25
Accepted
2024-06-25 16:08:58
Documents
1
Period of Report
2024-06-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4114
  Complete submission text file 0001578563-24-000320.txt   5643
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address
VARKI PAUL (Reporting) CIK: 0001677896 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 241069014